Venclose™ RF Ablation Catheter
For patients with Chronic Venous Disease (CVD), the Venclose™ RF Ablation Catheter is used for treatment of superficial vein reflux through endovenous radiofrequency (RF) ablation. RF ablation has been established as a CVD treatment option for more than 20 years.
In the U.S., an estimated 175 million Americans are affected by Chronic Venous Disease (CVD). Risk of CVD increases with age, but can begin as early as adolescence. Visible venous disease is far more than a cosmetic problem.6,8,9 CVD is a progressive disease. Without treatment, signs and symptoms may worsen.7
* Age ranges differ for prevalence population based on disease state, rates reported for years ranging from 2015 to 2020.
* As of February 2023
1 Alzheimer’s Association. 2020 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2020;16(3) :391-460.
2 American Heart Association. Heart Disease and Stroke Statistics-2020 Update. Circulation. 2020;141:e139-e596.
3 American Cancer Society. Cancer Facts and Figures 2020. Atlanta: American Cancer Society; 2020.
4 Yost ML. United States Critical Limb Ischemia by Rutherford Category Prevalence and Markets in Patients and Limbs. Beaufort, SC: The Sage Group 2017.
5 Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020.
6 Yost ML. Chronic Venous Disease (CVD): Epidemiology, costs, and consequences. Beaufort, SC: The Sage Group 2016.
7 Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):333-346.
8 Schultz-Ehrenburg U, Reich-Schupke S, Robak-Pawelczyk B, et al. Prospective epidemiological study on the beginning of varicose veins. Phlebologi. 2009;38(01):17-25. doi: 10.1055/s-0037-1622252
9 Criqui MH, Denenberg JO, Langer RD, Kaplan RM, Fronek A. Epidemiology of chronic peripheral venous disease. In Bergan J, ed. The Vein Book, 1st ed. Academic Press; 2006.
Please consult product labels and instructions for use for indications, contraindications, hazards, warnings, and precautions. BD, the BD Logo, and Venclose are trademarks of Becton, Dickinson and Company or its affiliates. All other trademarks are the property of their respective owners. © 2023 BD. All Rights Reserved. © 2023 Illustration by Mike Austin.
BD-69486 | MK-0112.A
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.